RESUMEN
Dietary factors influence male reproductive function in both experimental and epidemiological studies. However, there are currently no specific dietary guidelines for male preconception health. Here, we use the Nutritional Geometry framework to examine the effects of dietary macronutrient balance on reproductive traits in C57BL/6 J male mice. Dietary effects are observed in a range of morphological, testicular and spermatozoa traits, although the relative influence of protein, fat, carbohydrate, and their interactions differ depending on the trait being examined. Interestingly, dietary fat has a positive influence on sperm motility and antioxidant capacity, differing to typical high fat diet studies where calorie content is not controlled for. Moreover, body adiposity is not significantly correlated with any of the reproductive traits measured in this study. These results demonstrate the importance of macronutrient balance and calorie intake on reproductive function and support the need to develop specific, targeted, preconception dietary guidelines for males.
Asunto(s)
Adiposidad , Carbohidratos de la Dieta , Animales , Ratones , Masculino , Ratones Endogámicos C57BL , Motilidad Espermática , Dieta , Obesidad , Nutrientes , Grasas de la Dieta/farmacología , Dieta Alta en Grasa/efectos adversos , Proteínas en la DietaRESUMEN
INTRODUCTION: We examined the clinical relevance of urinary concentrations of B-cell-activating factor of the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) in systemic lupus erythematosus (SLE). METHODS: We quantified urinary BAFF (uBAFF) by enzyme-linked immunosorbent assay in 85 SLE, 28 primary Sjögren syndrome (pSS), 40 immunoglobulin A nephropathy (IgAN) patients and 36 healthy controls (HCs). Urinary APRIL (uAPRIL) and monocyte chemoattractant protein 1 (uMCP-1) were also quantified. Overall and renal SLE disease activity were assessed using the Systemic Lupus Erythematosus Disease Activity Index 2000. RESULTS: uBAFF was detected in 12% (10/85) of SLE patients, but was undetectable in HCs, IgAN and pSS patients. uBAFF was detectable in 28% (5/18) of SLE patients with active nephritis vs 5/67 (7%) of those without ( p = 0.03), and uBAFF was significantly higher in active renal patients ( p = 0.02) and more likely to be detected in patients with persistently active renal disease. In comparison, uAPRIL and uMCP-1 were detected in 32% (25/77) and 46% (22/48) of SLE patients, respectively. While no difference in proportion of samples with detectable uAPRIL was observed between SLE, HCs and IgAN patients, both uAPRIL and uMCP-1 were significantly detectable in higher proportions of patients with active renal disease. CONCLUSIONS: uBAFF was detectable in a small but a significant proportion of SLE patients but not in other groups tested, and was higher in SLE patients with active renal disease.
Asunto(s)
Factor Activador de Células B/orina , Lupus Eritematoso Sistémico/orina , Nefritis Lúpica/orina , Adolescente , Adulto , Anciano , Australia , Biomarcadores/orina , Estudios de Casos y Controles , Quimiocina CCL2/orina , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Miembro 13 de la Superfamilia de Ligandos de Factores de Necrosis Tumoral/orina , Adulto JovenRESUMEN
Interleukin (IL)-10-producing B cells (B10 cells) have emerged as important regulatory elements with immunosuppressive roles. Chronic lymphocytic leukemia (CLL) B cells also secrete IL-10 and share features of B10 cells, suggesting a possible contribution of CLL B cells to immunosuppression in CLL patients. Factors controlling the emergence of B10 cells are not known. B-cell-activating factor of the tumor necrosis factor (TNF) family (BAFF) is critical for B-cell maturation and survival, and is implicated in the development and progression of CLL. We sought to investigate the role of BAFF in the emergence of IL-10-producing regulatory B cells in healthy donors and CLL patients. Here, we report that BAFF signaling promotes IL-10 production by CLL B cells in a mouse model of CLL and in CLL patients. Moreover, BAFF-mediated IL-10 production by normal and CLL B cells is mediated via its receptor transmembrane activator and cyclophilin ligand interactor. Our work uncovered a major targetable pathway important for the generation of regulatory B cells that is detrimental to immunity in CLL.
Asunto(s)
Linfocitos B Reguladores/inmunología , Interleucina-10/biosíntesis , Leucemia Linfocítica Crónica de Células B/inmunología , Proteína Activadora Transmembrana y Interactiva del CAML/fisiología , Animales , Factor Activador de Células B/sangre , Factor Activador de Células B/fisiología , Células Cultivadas , Humanos , Interleucina-10/sangre , Ratones , Ratones Endogámicos C57BL , Receptor Toll-Like 9/fisiologíaRESUMEN
We investigate the behavior of colloidal suspensions with different volume fractions confined between parallel walls under a range of steady shears. We model the particles using molecular dynamics (MD) with full hydrodynamic interactions implemented through the use of a lattice-Boltzmann (LB) fluid. A quasi-2d ordering occurs in systems characterized by a coexistence of coupled layers with different densities, order, and granular temperature. We present a phase diagram in terms of shear and volume fraction for each layer, and demonstrate that particle exchange between layers is required for entering the disordered phase.
RESUMEN
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of CD5(+)CD19(+) B cells in the peripheral blood, and in primary and secondary lymphoid organs. A major complication associated with CLL is severe recurrent infections, which are often fatal. Vulnerability to infection is due to a wide variety of immunological defects, yet the initiating events of immunodeficiency in CLL are unclear. Using CLL patient samples and a mouse model of CLL, we have discovered that plasmacytoid dendritic cells (pDCs), which underpin the activity of effector immune cells critical for anti-viral immunity and anti-tumor responses, are reduced in number and functionally impaired in progressive CLL. As a result, the levels of interferon alpha (IFNα) production, a cytokine critical for immunity, are markedly reduced. Lower pDC numbers with impaired IFNα production was due to the decreased expression of FMS-like tyrosine kinase 3 receptor (Flt3) and Toll-like receptor 9 (TLR9), respectively. Reduced Flt3 expression was reversed using inhibitors of TGF-ß and TNF, an effect correlating with a reduction in tumor load. Defects in pDC numbers and function offer new insight into mechanisms underpinning the profound immunodeficiency affecting CLL patients and provide a potentially novel avenue for restoring immunocompetency in CLL.
Asunto(s)
Citocinas/metabolismo , Células Dendríticas/citología , Regulación Leucémica de la Expresión Génica , Leucemia Linfocítica Crónica de Células B/inmunología , Leucemia Linfocítica Crónica de Células B/metabolismo , Animales , Antineoplásicos/química , Islas de CpG , Progresión de la Enfermedad , Humanos , Interferón-alfa/metabolismo , Linfocitos/citología , Ratones , Receptor Toll-Like 9/metabolismo , Factor de Crecimiento Transformador beta/metabolismo , Tirosina Quinasa 3 Similar a fms/metabolismoRESUMEN
We use a Landau de Gennes free energy approach to model a diamond colloidal crystal immersed in a cholesteric liquid crystal. The pitch in our cholesteric is chosen in order to give rise to the most energetically favourable colloid-defect structure, commensurate with the diamond lattice. This structure corresponds to defect lines travelling along symmetry axes in the diamond crystal. By adding noise to the liquid crystal phase we are able to measure the phonon spectrum of our colloidal crystal, which we find to be consistent with a locally stable configuration. Therefore, although it may not correspond to the global minimum energy structure, once formed our diamond lattice should be stable against thermal fluctuations.
RESUMEN
INTRODUCTION: The objective of this study is to determine whether serum concentrations of B cell activating factor from the tumour necrosis factor family (BAFF) and/or a proliferation-inducing ligand (APRIL) are associated with clinical manifestations of systemic lupus erythematosus (SLE). METHODS: BAFF and APRIL concentrations were quantified using a commercial ELISA in serum samples obtained at the time of clinical assessment in 98 patients, and on 245 samples from 75 of these patients followed prospectively. RESULTS: Serum BAFF was significantly increased, and APRIL decreased, in patients with either renal or central nervous system (CNS) lupus. In contrast, in cross-sectional analysis, there was no correlation between disease activity (SLEDAI-2k) and serum BAFF or APRIL. In longitudinal follow-up, there was no association between changes in serum BAFF or APRIL and changes in SLEDAI-2k, or between baseline serum BAFF or APRIL and subsequent changes in SLEDAI-2k. However, between-visit changes in BAFF were significantly different in patients with increases in SLEDAI-2k ≥ 4, compared to patients whose SLEDAI-2k did not change. CONCLUSIONS: Although neither serum BAFF nor APRIL correlated with disease activity in the overall population, elevated serum BAFF and reduced APRIL may be markers of renal and CNS disease in SLE patients.
Asunto(s)
Factor Activador de Células B/sangre , Lupus Eritematoso Sistémico/fisiopatología , Miembro 13 de la Superfamilia de Ligandos de Factores de Necrosis Tumoral/sangre , Adulto , Estudios Transversales , Ensayo de Inmunoadsorción Enzimática , Femenino , Estudios de Seguimiento , Humanos , Estudios Longitudinales , Lupus Eritematoso Sistémico/sangre , Nefritis Lúpica/sangre , Nefritis Lúpica/fisiopatología , Vasculitis por Lupus del Sistema Nervioso Central/sangre , Vasculitis por Lupus del Sistema Nervioso Central/fisiopatología , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Índice de Severidad de la EnfermedadRESUMEN
The incidence and prevalence of autoimmune diseases such as rheumatoid arthritis, primary Sjögren syndrome, scleroderma and systemic lupus erythematosus (SLE) varies with geography and ethnicity. For example, SLE is reported to be more common in populations such as African-Caribbeans and Indigenous Australians (IA). As well as socio-economic status, variation in severity of disease may also show ethnic variability. The initial presentation of SLE in IA, in the context of a unique genetic background and distinctive environmental influences, is often florid with a recurring spectrum of clinical phenotypes. These clinical observations suggest a unique pathway for autoimmunity pathogenesis in this population. For instance, the high prevalence of bacterial infections in IA, particularly group A streptococcus, may be a potential explanation not only for increased incidence and prevalence of SLE but also the commonly florid acute disease presentation and propensity for rapidly progressive end organ threatening disease. This article will review the state of research in autoimmune disease of IA, consider key findings related to autoimmune disease in this population and propose a model potentially to explain the involvement of innate immunity and chronic infection in autoimmune disease pathogenesis. Ultimately, understanding of SLE at this level could affect management and result in personalised and targeted therapies to improve the health status of IA as well as better understanding of SLE pathogenesis per se.
Asunto(s)
Enfermedades Autoinmunes/etnología , Lupus Eritematoso Sistémico/diagnóstico , Lupus Eritematoso Sistémico/etnología , Nativos de Hawái y Otras Islas del Pacífico/etnología , Australia/etnología , Enfermedades Autoinmunes/diagnóstico , Enfermedades Autoinmunes/inmunología , Humanos , Inmunidad Innata/inmunología , Lupus Eritematoso Sistémico/inmunologíaRESUMEN
BACKGROUND: Obesity and type 2 diabetes mellitus are characterized by insulin resistance and 'low-grade inflammation'; however, the pathophysiological link is poorly understood. To determine the relative contribution of obesity and insulin resistance to systemic 'inflammation', this study comprehensively characterized circulating immune cells in different grades of obesity. METHODS: Immune cell phenotypes and activation status were analysed by flow cytometry cross-sectionally in morbidly obese (n = 16, body mass index (BMI) 42.2 ± 5.4 kg/m2), overweight (n = 13, BMI 27.4 ± 1.6 kg/m2) and normal weight (n = 12, BMI 22.5 ± 1.9 kg/m2) subjects. RESULTS: Obese, but not overweight subjects, had increased activation marker expression on neutrophils, monocytes, T-lymphocytes and polarization of T helper cells towards a pro-inflammatory type 1-phenotype (Th1). Th1 numbers correlated positively with the degree of insulin resistance (homeostasis model assessment, p < 0.05). Lymphocytes from obese subjects showed reduced insulin-stimulated AKT-phosphorylation in vitro. Supra-physiological insulin concentrations did not affect T-cell differentiation, which under normal circumstances would promote an anti-inflammatory T helper type 2-phenotype. CONCLUSIONS: These results show that morbid obesity is characterized by circulating immune cells that are activated and insulin resistant, with the T-cell balance polarized towards a pro-inflammatory Th1 phenotype. The loss of insulin-induced suppression of inflammatory phenotypes in circulating immune cells could contribute to the systemic and adipose tissue inflammation found in morbid obesity.
Asunto(s)
Biomarcadores/metabolismo , Diabetes Mellitus Tipo 2/etiología , Inflamación/inmunología , Resistencia a la Insulina , Células Secretoras de Insulina/inmunología , Obesidad Mórbida/complicaciones , Linfocitos T/inmunología , Tejido Adiposo/inmunología , Tejido Adiposo/metabolismo , Composición Corporal , Índice de Masa Corporal , Diabetes Mellitus Tipo 2/metabolismo , Femenino , Citometría de Flujo , Humanos , Inflamación/metabolismo , Insulina/metabolismo , Células Secretoras de Insulina/metabolismo , Masculino , Persona de Mediana Edad , Sobrepeso/inmunología , Sobrepeso/metabolismo , Linfocitos T/metabolismoRESUMEN
B cells undergo a complex series of maturation and selection steps in the bone marrow and spleen during differentiation into mature immune effector cells. The tumor necrosis factor (TNF) family member B cell activating factor of the TNF family (BAFF) (BLyS/TALL-1) plays an important role in B cell homeostasis. BAFF and its close homologue a proliferation-inducing ligand (APRIL) have both been shown to interact with at least two receptors, B cell maturation antigen (BCMA) and transmembrane activator and cyclophilin ligand interactor (TACI), however their relative contribution in transducing BAFF signals in vivo remains unclear. To functionally inactivate both BAFF and APRIL, mice transgenic for a soluble form of TACI were generated. They display a developmental block of B cell maturation in the periphery, leading to a severe depletion of marginal zone and follicular B2 B cells, but not of peritoneal B1 B cells. In contrast, mice transgenic for a soluble form of BCMA, which binds APRIL, have no detectable B cell phenotype. This demonstrates a crucial role for BAFF in B cell maturation and strongly suggests that it signals via a BCMA-independent pathway and in an APRIL-dispensable way.
Asunto(s)
Linfocitos B/citología , Proteínas de la Membrana/metabolismo , Receptores del Factor de Necrosis Tumoral/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Animales , Factor Activador de Células B , Antígeno de Maduración de Linfocitos B , Linfocitos B/fisiología , Diferenciación Celular , Humanos , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Ratones Transgénicos , Receptores del Factor de Necrosis Tumoral/genética , Proteína Activadora Transmembrana y Interactiva del CAML , Miembro 13 de la Superfamilia de Ligandos de Factores de Necrosis TumoralRESUMEN
The novel G-protein, G(h)/tissue transglutaminase (TGase II), has both guanosine triphosphatase and Ca(2+)-activated transglutaminase activity and has been implicated in a number of processes including signal transduction, apoptosis, bone ossification, wound healing, and cell adhesion and spreading. To determine the role of G(h) in vivo, the Cre/loxP site-specific recombinase system was used to develop a mouse line in which its expression was ubiquitously inactivated. Despite the absence of G(h) expression and a lack of intracellular TGase activity that was not compensated by other TGases, the Tgm2(-/-) mice were viable, phenotypically normal, and were born with the expected Mendelian frequency. Absence of G(h) coupling to alpha(1)-adrenergic receptor signaling in Tgm2(-/-) mice was demonstrated by the lack of agonist-stimulated [alpha-(32)P]GTP photolabeling of a 74-kDa protein in liver membranes. Annexin-V positivity observed with dexamethasone-induced apoptosis was not different in Tgm2(-/-) thymocytes compared with Tgm2(+/+) thymocytes. However, with this treatment there was a highly significant decrease in the viability (propidium iodide negativity) of Tgm2(-/-) thymocytes. Primary fibroblasts isolated from Tgm2(-/-) mice also showed decreased adherence with culture. These results indicate that G(h) may be importantly involved in stabilizing apoptotic cells before clearance, and in responses such as wound healing that require fibroblast adhesion mediated by extracellular matrix cross-linking.
Asunto(s)
Transglutaminasas/antagonistas & inhibidores , Proteínas Virales , Animales , Secuencia de Bases , Cartilla de ADN , Integrasas/genética , Ratones , Ratones Noqueados , Ratones Transgénicos , Fenotipo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transglutaminasas/genética , Transglutaminasas/fisiologíaRESUMEN
It has not been established whether an endogenous superantigen (SAg) expressed on B cells can induce germinal centers (GCs). An interesting model is that of mammary tumor virus encoded viral SAgs, which induce vigorous T cell proliferation and are predominantly expressed on activated B cells. We have used this model to analyze the possibility that direct stimulation of Mtv7+ DBA/2 B cells by vSAg-responsive (Vbeta6+) BALB/c T cells can give rise to GCs. Injection of BALB/c SCID mice i.v. with 2 x 10(6) DBA/2 B cells, together with LPS, followed by 2 x 10(6) BALB/c T cells induces numerous large splenic GCs within 3-5 days. The GCs are still large on day 7, but are very much reduced by day 10. B cell activation with LPS is needed for this effect. These GCs form in spite of the apparent absence of follicular dendritic cells (FDCs) as judged by staining for several FDC surface markers. Control mice receiving either BALB/c T or DBA/2 B cells + LPS alone or DBA/2 T + B cells + LPS fail to exhibit any GCs on days 3-7. Numerous small clusters of PNA+ cells, but few large GCs are observed when TNF-R(p55)-Ig is also injected, whereas LTbetaR-Ig treatment impeded the formation of aggregations of these cells even further, leaving scattered PNA+ single cells and very small clumps throughout the white pulp of the spleens. Anti-TNFalpha had no effect. These results suggest that endogenous vSAg mediated GC formation is independent of antigen trapping by FDCs.
Asunto(s)
Antígenos Virales/inmunología , Linfocitos B/inmunología , Centro Germinal/inmunología , Virus del Tumor Mamario del Ratón/inmunología , Glicoproteínas de Membrana/inmunología , Animales , Presentación de Antígeno , Antígenos CD/metabolismo , Células Cultivadas , Lipopolisacáridos/farmacología , Activación de Linfocitos , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos DBA , Ratones SCID , Receptores del Factor de Necrosis Tumoral/metabolismo , Receptores Tipo I de Factores de Necrosis Tumoral , Bazo/citología , Bazo/inmunología , Linfocitos T/inmunologíaRESUMEN
B cell maturation is a very selective process that requires finely tuned differentiation and survival signals. B cell activation factor from the TNF family (BAFF) is a TNF family member that binds to B cells and potentiates B cell receptor (BCR)-mediated proliferation. A role for BAFF in B cell survival was suggested by the observation of reduced peripheral B cell numbers in mice treated with reagents blocking BAFF, and high Bcl-2 levels detected in B cells from BAFF transgenic (Tg) mice. We tested in vitro the survival effect of BAFF on lymphocytes derived from primary and secondary lymphoid organs. BAFF induced survival of a subset of splenic immature B cells, referred to as transitional type 2 (T2) B cells. BAFF treatment allowed T2 B cells to survive and differentiate into mature B cells in response to signals through the BCR. The T2 and the marginal zone (MZ) B cell compartments were particularly enlarged in BAFF Tg mice. Immature transitional B cells are targets for negative selection, a feature thought to promote self-tolerance. These findings support a model in which excessive BAFF-mediated survival of peripheral immature B cells contributes to the emergence and maturation of autoreactive B cells, skewed towards the MZ compartment. This work provides new clues on mechanisms regulating B cell maturation and tolerance.
Asunto(s)
Autoinmunidad , Subgrupos de Linfocitos B/inmunología , Células Madre Hematopoyéticas/inmunología , Proteínas de la Membrana/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Animales , Factor Activador de Células B , Subgrupos de Linfocitos B/citología , Diferenciación Celular , Supervivencia Celular , Células Cultivadas , Células Madre Hematopoyéticas/citología , Ratones , Modelos Inmunológicos , Bazo/citología , Bazo/inmunologíaAsunto(s)
Células Dendríticas Foliculares , Enfermedades por Prión/prevención & control , Receptores del Factor de Necrosis Tumoral/uso terapéutico , Animales , Modelos Animales de Enfermedad , Inmunoglobulinas/genética , Receptor beta de Linfotoxina , Ratones , Receptores del Factor de Necrosis Tumoral/genética , Proteínas Recombinantes de Fusión/uso terapéutico , Scrapie/prevención & controlRESUMEN
The tumor necrosis factor (TNF) family member B cell activating factor (BAFF) binds B cells and enhances B cell receptor-triggered proliferation. We find that B cell maturation antigen (BCMA), a predicted member of the TNF receptor family expressed primarily in mature B cells, is a receptor for BAFF. Although BCMA was previously localized to the Golgi apparatus, BCMA was found to be expressed on the surface of transfected cells and tonsillar B cells. A soluble form of BCMA, which inhibited the binding of BAFF to a B cell line, induced a dramatic decrease in the number of peripheral B cells when administered in vivo. Moreover, culturing splenic cells in the presence of BAFF increased survival of a percentage of the B cells. These results are consistent with a role for BAFF in maintaining homeostasis of the B cell population.
Asunto(s)
Linfocitos B/inmunología , Activación de Linfocitos , Proteínas de la Membrana/inmunología , Proteínas de la Membrana/fisiología , Receptores del Factor de Necrosis Tumoral/inmunología , Receptores del Factor de Necrosis Tumoral/fisiología , Factor de Necrosis Tumoral alfa , Animales , Factor Activador de Células B , Antígeno de Maduración de Linfocitos B , Línea Celular , Supervivencia Celular , Homeostasis , Humanos , Inmunoglobulina G/inmunología , Cadenas kappa de Inmunoglobulina/genética , Cadenas kappa de Inmunoglobulina/inmunología , Proteínas de la Membrana/genética , Ratones , Ratones Endogámicos BALB C , Tonsila Palatina/inmunología , Receptores del Factor de Necrosis Tumoral/genética , Proteínas Recombinantes/inmunología , Bazo/inmunología , TransfecciónRESUMEN
In scrapie-infected mice, prions are found associated with splenic but not circulating B and T lymphocytes and in the stroma, which contains follicular dendritic cells (FDCs). Formation and maintenance of mature FDCs require the presence of B cells expressing membrane-bound lymphotoxin-alpha/beta. Treatment of mice with soluble lymphotoxin-beta receptor results in the disappearance of mature FDCs from the spleen. We show that this treatment abolishes splenic prion accumulation and retards neuroinvasion after intraperitoneal scrapie inoculation. These data provide evidence that FDCs are the principal sites for prion replication in the spleen.
Asunto(s)
Células Dendríticas Foliculares/patología , Células Dendríticas Foliculares/virología , Proteínas PrPSc/biosíntesis , Bazo/patología , Bazo/virología , Replicación Viral/inmunología , Animales , Diferenciación Celular/genética , Diferenciación Celular/inmunología , Células Dendríticas Foliculares/metabolismo , Inmunoglobulinas/genética , Receptor beta de Linfotoxina , Linfotoxina-alfa/antagonistas & inhibidores , Linfotoxina-alfa/genética , Linfotoxina-alfa/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones SCID , Proteínas PrPSc/administración & dosificación , Receptores del Factor de Necrosis Tumoral/antagonistas & inhibidores , Receptores del Factor de Necrosis Tumoral/genética , Receptores del Factor de Necrosis Tumoral/inmunología , Proteínas Recombinantes de Fusión/administración & dosificación , Scrapie/inmunología , Scrapie/metabolismo , Transducción de Señal/genética , Transducción de Señal/inmunología , Bazo/inmunología , Bazo/metabolismo , Replicación Viral/genéticaRESUMEN
The cause of many autoimmune and inflammatory diseases is unresolved, although dysregulated production of tumor necrosis factor (TNF) family members appears to be important in many cases. BAFF, a new member of the TNF family, binds to B cells and costimulates their growth in vitro. Mice transgenic for BAFF have vastly increased numbers of mature B and effector T cells, and develop autoimmune-like manifestations such as the presence of high levels of rheumatoid factors, circulating immune complexes, anti-DNA autoantibodies, and immunoglobulin deposition in the kidneys. This phenotype is reminiscent of certain human autoimmune disorders and suggests that dysregulation of BAFF expression may be a critical element in the chain of events leading to autoimmunity.
Asunto(s)
Autoanticuerpos/sangre , Enfermedades Autoinmunes/inmunología , Linfocitos B/inmunología , Enfermedades Linfáticas/inmunología , Proteínas de la Membrana/genética , Proteínas de la Membrana/inmunología , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/inmunología , Animales , Anticuerpos Antinucleares/sangre , Enfermedades Autoinmunes/genética , Enfermedades Autoinmunes/patología , Factor Activador de Células B , Citometría de Flujo , Humanos , Inmunoglobulina A/sangre , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Inmunoglobulinas/metabolismo , Riñón/inmunología , Riñón/patología , Cinética , Recuento de Leucocitos , Pulmón/inmunología , Enfermedades Linfáticas/genética , Enfermedades Linfáticas/patología , Ratones , Ratones Transgénicos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor Reumatoide/sangre , Linfocitos T/inmunologíaRESUMEN
The objective of this study was to undertake a post- marketing safety surveillance study of losartan, the first specific angiotensin-II receptor antagonist to be marketed in England. It is a non-interventional observational cohort study using the technique of prescription-event monitoring. Subjects who took part in the study were from 14 522 patients treated by general practitioners in England. We recorded adverse drug reactions, adverse events, reasons for stopping the drug, pregnancies and deaths. The results were that general practitioners considered the drug to have been effective in 85.9% of the patients evaluated for effectiveness. Dizziness, malaise, lassitude, nausea, cough and headache were among the most frequently reported adverse drug reactions, reasons for stopping the drug and events of highest incidence density. None of the deaths that occurred were attributed to losartan and no serious unexpected adverse reactions or interactions were identified. In conclusion losartan has an acceptable safety profile and the study confirms the safety information given in the current Summary of Product characteristics for losartan.
Asunto(s)
Antihipertensivos/efectos adversos , Losartán/efectos adversos , Vigilancia de Productos Comercializados , Distribución por Edad , Anciano , Estudios de Cohortes , Tos/inducido químicamente , Tos/epidemiología , Mareo/inducido químicamente , Mareo/epidemiología , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Embarazo , Complicaciones del Embarazo/inducido químicamente , Vigilancia de Productos Comercializados/estadística & datos numéricos , Trastornos Respiratorios/inducido químicamente , Trastornos Respiratorios/epidemiologíaRESUMEN
Members of the tumor necrosis factor (TNF) family induce pleiotropic biological responses, including cell growth, differentiation, and even death. Here we describe a novel member of the TNF family, designated BAFF (for B cell activating factor belonging to the TNF family), which is expressed by T cells and dendritic cells. Human BAFF was mapped to chromosome 13q32-34. Membrane-bound BAFF was processed and secreted through the action of a protease whose specificity matches that of the furin family of proprotein convertases. The expression of BAFF receptor appeared to be restricted to B cells. Both membrane-bound and soluble BAFF induced proliferation of anti-immunoglobulin M-stimulated peripheral blood B lymphocytes. Moreover, increased amounts of immunoglobulins were found in supernatants of germinal center-like B cells costimulated with BAFF. These results suggest that BAFF plays an important role as costimulator of B cell proliferation and function.
Asunto(s)
Linfocitos B/inmunología , Proteínas de la Membrana/fisiología , Receptores del Factor de Necrosis Tumoral/fisiología , Factor de Necrosis Tumoral alfa/fisiología , Secuencia de Aminoácidos , Animales , Factor Activador de Células B , Linfocitos B/citología , Secuencia de Bases , División Celular , Línea Celular , Mapeo Cromosómico , Cromosomas Humanos Par 13/genética , Clonación Molecular , Cartilla de ADN/genética , Células Dendríticas/inmunología , Humanos , Ligandos , Activación de Linfocitos , Proteínas de la Membrana/genética , Ratones , Datos de Secuencia Molecular , Receptores del Factor de Necrosis Tumoral/genética , Homología de Secuencia de Aminoácido , Linfocitos T/inmunología , Factor de Necrosis Tumoral alfa/genéticaRESUMEN
AIMS: Cough is one of the most frequent side effects associated with angiotensin converting enzyme inhibitors (ACEIs) but is not thought to be associated with losartan, an angiotensin II receptor antagonist (ARA). This study compares reports of cough with losartan and three ACEIs used in general practice. METHODS: Studies have been conducted for losartan, and three ACEIs enalapril, lisinopril and perindopril, using the technique of Prescription-Event Monitoring. Patients were identified using dispensed prescription data. Questionnaires were sent to patients' general practitioners 6 months after the date of first prescription. Cases of cough within the first 60 days of treatment with losartan resulting in withdrawal of the drug were followed up with additional questionnaires. Incidence rates for reports of cough were calculated. In order to reduce the impact of carry-over effects, rate ratios were calculated for first reports of cough between days 8 and 60 using losartan as the index drug. RESULTS: The cohort for each drug exceeded 9000 patients. Age and sex distributions and indications for prescribing the four drugs were similar. Cough was the most frequent reason for discontinuation of losartan and the most frequently reported event in the first month of treatment with this drug. When reports of cough between days 1-7 were excluded, rates of cough were significantly higher for the three ACEIs when compared with losartan (rate ratios 1.5, 4.8 and 5.7, all P<0.03). 101 patients had discontinued losartan due to cough. 91% of these had previously been prescribed an ACEI and 86% had previously experienced ACEI cough. CONCLUSIONS: Carry-over accounted for the observed excess of reports of cough with losartan. Rates of cough between days 8 and 60 were significantly higher for the three ACEIs compared with losartan. Confounding factors associated with comparative observational cohort studies are discussed.